Set Your Location to See Relevant Information

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.

An Observational Study of Individuals with Isolated Dystonia

Objective

ClinicalTrials.gov ID: NCT07111663
Ages Eligible: 12 Years to 65 Years
Sexes Eligible: All
Study Type: Observational
Study Completion (Estimated):

Principal Investigator: Dr. Pinky Agarwal

Contact Information:

EvergreenHealth Research Department
425-899-5385
EvergreenResearch@evergreenhealthcare.org

Summary:

This is an observational study in individuals with isolated (or primary) dystonia that involves more than one body region. The purpose of the study is to collect detailed information to help your physician and other researchers understand how dystonia impacts your and other patients' lives and how the disease changes over time. The study may also help researchers better understand the clinical scales that are commonly used to evaluate dystonia symptoms and how they affect various areas of life such as well-being, pain, relationships and social interactions, and progress over time. Because this is an observational study, you will not receive any interventional treatment in the study.

Eligibility Criteria:

Inclusion Criteria

Each participant must meet the following criteria at Visit 1 to be eligible to continue in the study:

  • The participant is willing to sign an informed consent form indicating that he/she understands the purpose of the study; understands and can perform, complete, and comply with all the assessments that are required during the study; and is willing to participate in the study.
  • The participant is a male or female between 12 and 65 years of age (inclusive).
  • The participant has a clinical diagnosis of isolated (or primary) dystonia for at least one year prior to Visit 1 and meets the study definition of segmental/multifocal or generalized dystonia at Visit 1.

Exclusion Criteria

Any participant who meets any of the following criteria at Visit 1 will be excluded from this study:

  • The participant has a diagnosis of focal dystonia at Visit 1.
  • The participant has a diagnosis of dopa-responsive dystonia, secondary dystonia, or psychogenic/functional dystonia.
  • The participant has any significant ongoing disease, disorder, laboratory abnormalities, alcohol or illicit drug abuse or dependence, environmental factor, or any ongoing or history of any medical or surgical condition that in the judgment of the investigator, in consultation with the medical monitor and/or sponsor's designee, might jeopardize the participant's safety, impact the scientific objectives of the clinical study, or interfere with participation in the clinical study.
  • The participant has a history of any psychiatric or cognitive impairment disorder that, in the opinion of the investigator, may interfere with study conduct.
  • The participant has had myotomy or denervation surgery in any affected muscles (e.g., peripheral denervation and/or spinal cord stimulation).
  • The participant has marked limitation on passive range of motion that suggests contractures or other structural abnormality (e.g., cervical contractures or cervical spine syndrome).
  • The participant has undergone deep brain stimulation (DBS) surgery (even if implant deactivated).

Clinical Trial Categories

  • Dystonia

Location

  • EvergreenHealth Clinical Trials
    12040 NE 128th Street, Red 1-570
    Kirkland, WA 98034
    Main: 425-899-5385

Contact Us

Call us at (425) 899-5385 or use our online information request form.

Online Form